• Register
  • Login
  • Home
  • Ahead of print
  • Current
  • Archives
  • Submissions
  • Supplements
  • About
    About the Journal Editorial Team Contact Privacy Statement
  • Login
  • Register
Journal of Gastrointestinal and Liver Diseases
Article References Download Details Statistics
  • PDF
  • Abstract viewed - 0 times
  • PDF downloaded - 0 times

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Affiliations

Susumu Ohya
Department of Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan

Miki Matsui
Department of Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan

Junko Kajikuri
Department of Pharmacology, Graduate School of Medical Sciences, Nagoya City University, Nagoya, Japan

How to Cite

1.
Ohya S, Matsui M, Kajikuri J. Ca 2+ -Activated K + Channel K Ca 3.1 as a Double-Edged Sword in the Treatment of Inflammatory Bowel Disease. JGLD [Internet]. 12Dec.2020 [cited 15Apr.2021];29(4):487-9. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/3234
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Download Citation

Endnote/Zotero/Mendeley (RIS) BibTeX
Content Top

Ca 2+ -Activated K + Channel K Ca 3.1 as a Double-Edged Sword in the Treatment of Inflammatory Bowel Disease

  1. Susumu Ohya ,
  2. Miki Matsui ,
  3. Junko Kajikuri

Vol 29 No 4: December 2020

Section: Editorial

Pages: 487-489

DOI 10.15403/jgld-3234